Osmotica Pharm Corp Company Profile
✉ Email this page to a colleague
What is the competitive landscape for OSMOTICA PHARM CORP, and what generic and branded alternatives to OSMOTICA PHARM CORP drugs are available?
OSMOTICA PHARM CORP has one approved drug.
Drugs and US Patents for Osmotica Pharm Corp
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Osmotica Pharm Corp | KHEDEZLA | desvenlafaxine | TABLET, EXTENDED RELEASE;ORAL | 204683-001 | Jul 10, 2013 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Osmotica Pharm Corp | KHEDEZLA | desvenlafaxine | TABLET, EXTENDED RELEASE;ORAL | 204683-002 | Jul 10, 2013 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.